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Background:  Diabetic cardiomyopathy, characterized by myocardial structural and functional changes, is a specific cardiomyopathy develops in 
patients with diabetes mellitus. The present study was to investigate the role of kinin B2 receptor-Akt-glycogen synthase kinase (GSK)-3`signalling 
pathway in mediating the protective effects of tanshinone IIA (TSN) on diabetic cardiomyopathy.
Methods:  Streptozocin (STZ) induced diabetic rats (n=60) were randomized to receive TSN, TSN plus HOE140 (a kinin B2 receptor antagonist), or 
saline. Healthy Sprague-Dawley (SD) rats (n=20) were used as control. Left ventricular function, myocardial apoptosis, fibrosis, collagen deposition, 
myocardial untrastructure, Akt, GSK-3` and NF-gB phosphorylation, the expression of TNF-_ , IL-6 and MPO were examined.
Results: Cardiac function was well preserved as evidenced by increased left ventricular ejection fraction (LVEF) and ±dp/dt (maximum speed of 
contraction / relaxation), along with decreased myocardial apoptotic death, cardiac fibrosis and collagen deposition levels after TSN administration. 
While TSN pretreatment alleviated mitochondria ultrastructure changes. TSN also enhanced Akt and GSK-3` phosphorylation and inhibited NF-gB 
phosphorylation, resulting in decreased TNF-_ , IL-6 and MPO activities. Moreover, pretreatment with HOE140 abolished the beneficial effects of 
TSN: a decrease in LVEF and ±dp/dt, an inhibition of cardiomyocyte apoptosis, an increase in cardiac fibrosis and collagen deposition, a destruction 
of cardiomyocyte mitochondria cristae, a reduction of Akt and GSK-3` phosphorylation, an enhancement of NF-gB phosphorylation and an increase 
of TNF-_ , IL-6 and MPO production.
Conclusions:  These data indicated that TSN is cardioprotective in the context of diabetic cadiomyopathy through kinin B2 receptor-Akt-GSK-3` 
dependent pathway.
